Acousia Therapeutics GmbH

Acousia is committed to identifying and developing novel compounds (small molecules) to preserve and enhance natural hearing for patients suffering from sensorineural hearing loss (SNHL), which make up over 90 percent of those affected by hearing loss. The company aims to make hearing loss treatable for the growing number of people affected so they can stay connected and fully participate in life.